BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 27765935)

  • 1. Gene polymorphisms are associated with clinical outcome in Chinese resected laryngeal carcinoma patients.
    Chen P; Chen Z; Li J; Yang H; Zhu Y; Zhang N; Yan M; Shao Y; Chen C; Jin T
    Oncotarget; 2016 Nov; 7(44):71703-71709. PubMed ID: 27765935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADH1B and CDH1 polymorphisms predict prognosis in male patients with non-metastatic laryngeal cancer.
    Li D; Zhang R; Jin T; He N; Ren L; Zhang Z; Zhang Q; Xu R; Tao H; Zeng G; Gao J
    Oncotarget; 2016 Nov; 7(45):73216-73228. PubMed ID: 27689323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of genetic polymorphisms with laryngeal carcinoma prognosis in a Chinese population.
    Quan F; Zhang F; Bai Y; Zhou L; Yang H; Li B; Jin T; Li H; Shao Y
    Oncotarget; 2017 Feb; 8(6):10255-10263. PubMed ID: 28052013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional polymorphisms of ATP citrate lyase gene predicts clinical outcome of patients with advanced colorectal cancer.
    Xie S; Zhou F; Wang J; Cao H; Chen Y; Liu X; Zhang Z; Dai J; He X
    World J Surg Oncol; 2015 Feb; 13():42. PubMed ID: 25890184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional polymorphisms of circadian positive feedback regulation genes and clinical outcome of Chinese patients with resected colorectal cancer.
    Zhou F; He X; Liu H; Zhu Y; Jin T; Chen C; Qu F; Li Y; Bao G; Chen Z; Xing J
    Cancer; 2012 Feb; 118(4):937-46. PubMed ID: 21773969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between GWAS-identified genetic variations and disease prognosis for patients with colorectal cancer.
    Kang BW; Jeon HS; Chae YS; Lee SJ; Park JY; Choi JE; Park JS; Choi GS; Kim JG
    PLoS One; 2015; 10(3):e0119649. PubMed ID: 25799222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of EGFR SNPs in survival of advanced lung adenocarcinoma patients treated with Gefitinib.
    Zhang L; Yuan X; Chen Y; Du XJ; Yu S; Yang M
    Gene; 2013 Mar; 517(1):60-4. PubMed ID: 23313300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer.
    Chen Z; Wang J; Bai Y; Wang S; Yin X; Xiang J; Li X; He M; Zhang X; Wu T; Xu P; Guo H
    Cancer Gene Ther; 2017 Jan; 24(1):20-27. PubMed ID: 27982019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in EGFR and VEGF contribute to non-small-cell lung cancer survival in a Chinese population.
    Dong J; Dai J; Shu Y; Pan S; Xu L; Chen W; Wang Y; Jin G; Ma H; Zhang M; Hu Z; Shen H
    Carcinogenesis; 2010 Jun; 31(6):1080-6. PubMed ID: 20400478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variations in SLC3A2/CD98 gene as prognosis predictors in non-small cell lung cancer.
    Guo X; Li H; Fei F; Liu B; Li X; Yang H; Chen Z; Xing J
    Mol Carcinog; 2015 Jun; 54 Suppl 1():E52-60. PubMed ID: 24782339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms of monocarboxylate transporter genes are associated with clinical outcomes in patients with colorectal cancer.
    Fei F; Guo X; Chen Y; Liu X; Tu J; Xing J; Chen Z; Ji J; He X
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):1095-102. PubMed ID: 25492048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in the base excision repair pathway modulate prognosis of platinum-based chemotherapy in advanced non-small cell lung cancer.
    Zhao W; Hu L; Xu J; Shen H; Hu Z; Ma H; Shu Y; Shao Y; Yin Y
    Cancer Chemother Pharmacol; 2013 May; 71(5):1287-95. PubMed ID: 23479135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The GNAS1 T393C polymorphism predicts survival in patients with advanced squamous cell carcinoma of the larynx.
    Lehnerdt GF; Franz P; Winterhoff S; Bankfalvi A; Grehl S; Lang S; Schmid KW; Siffert W; Jahnke K; Frey UH
    Laryngoscope; 2008 Dec; 118(12):2172-6. PubMed ID: 19029852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
    Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Suehiro Y; Tanaka Y; Dahiya R
    Clin Cancer Res; 2007 Jul; 13(14):4123-9. PubMed ID: 17634539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Putative functional polymorphisms of MMP9 predict survival of NSCLC in a Chinese population.
    Jin G; Miao R; Hu Z; Xu L; Huang X; Chen Y; Tian T; Wei Q; Boffetta P; Shen H
    Int J Cancer; 2009 May; 124(9):2172-8. PubMed ID: 19132754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-608 rs4919510 is associated with prognosis of hepatocellular carcinoma.
    Ma XP; Yu G; Chen X; Xiao Q; Shi Z; Zhang LY; Chen H; Zhang P; Ding DL; Huang HX; Saiyin H; Chen TY; Lu PX; Wang NJ; Yu H; Conran C; Sun J; Zheng SL; Xu J; Yu L; Jiang DK
    Tumour Biol; 2016 Jul; 37(7):9931-42. PubMed ID: 26815502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer.
    Guo X; Li D; Wu Y; Chen Y; Zhou X; Wang X; Huang X; Li X; Yang H; Xing J
    Lung Cancer; 2015 Feb; 87(2):162-8. PubMed ID: 25576295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variants in glucose-6-phosphate isomerase gene as prognosis predictors in hepatocellular carcinoma.
    Lyu Z; Chen Y; Guo X; Zhou F; Yan Z; Xing J; An J; Zhang H
    Clin Res Hepatol Gastroenterol; 2016 Dec; 40(6):698-704. PubMed ID: 27288297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
    Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S
    Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S4646 polymorphism in CYP19A1 gene is associated with the efficacy of hormone therapy in early breast cancer.
    Shao X; Cai J; Zheng Y; Wang J; Feng J; Huang Y; Shi L; Chen Z; Guo Y; Wang X
    Int J Clin Exp Pathol; 2015; 8(5):5309-17. PubMed ID: 26191232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.